Pediatrics

Emerging evidence is changing health care providers’ approach to treating pediatric rheumatic diseases.

This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.

Pharmacists can help at-risk youth with asthma through the CAReS program, providing school-based asthma care.

Surviving a bout of cancer early in life puts children and teenagers at risk of cancers linked to human papillomavirus (HPV). A phase 2 trial examined how effective a 3-dose series was in providing protection.

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

During a session at the 2021 American Academy of Pediatrics National Conference & Exhibition research revealed that introduction to common allergy foods early on can be key in decreasing the frequency of development in children.

Ocugen, Inc. has submitted a request to the FDA for emergency use authorization (EUA) of their COVID-19 vaccine candidate for use in children aged 2 to 18 years.

Initial results from the trial indicate it was well-tolerated and promoted a good immune response.

A press briefing from the Infectious Diseases Society of America focused on the concerns raised by the delta variant and its potential impact on schools.

To protect children and staff at schools, the Infectious Diseases Society of America (IDSA) has recommended using multiple science-based approaches to prevent spread in schools.

Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.

For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.

There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.

Viloxazine is a selective norepinephrine reuptake inhibitor and is the first new nonstimulant medication for treatment of ADHD in children in more than 10 years.

The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

The FDA has expanded the emergency use authorization for the COVID-19 vaccine to include individuals 12 to 15 years of age.

The approval marks the first novel non-stimulant treatment for ADHD.

Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.

A recent study examined how insulin levels and body mass index may have ties to mental health concerns.

Prefilled syringes have been the way that many children with juvenile idiopathic arthritis get their methotrexate. A pilot study examines if prefilled pens might be a better option.

Acetaminophen may be the antipyretic choice for many families, but a new study asks whether it could be a problem for children with asthma.

US health care workers have started receiving the COVID-19 vaccine, but we are still months away from approving the vaccine for use in children, according to Fauci.

In the wake of a resurgence of measles cases and deaths globally, experts are worried about the decline in vaccinations during the pandemic.

Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."

The FDA approved the treatment through the prescription-to-OTC switch process.

The program is designed to prepare state-licensed pharmacists to meet requirements for administering vaccinations to pediatric patients.